Canada Cannabis

Why Pre-Rolls Are Cannabis' Most Profitable Format, From California To Canada

Tilray Brands Reports Lower Cannabis Sales In Q3, Trims 2025 Revenue Outlook

Only 3% Of Cannabis Consumed In Canada Came From Illicit Sources, National Survey Shows

Tilray Brands Reports Lower Cannabis Sales In Q3, Trims 2025 Revenue Outlook

Only 3% Of Cannabis Consumed In Canada Came From Illicit Sources, National Survey Shows

Canopy Growth Wraps Up Acreage Acquisition Expanding US Cannabis Portfolio, What Investors Need To Know

Organigram Wants To Become Canada's Largest Cannabis Company By Market Share Via $71M Acquisition Deal

Canopy Growth Wraps Up Acreage Acquisition Expanding US Cannabis Portfolio, What Investors Need To Know

Organigram Wants To Become Canada's Largest Cannabis Company By Market Share Via $71M Acquisition Deal

Europe Says Thanks But We'll Do It Ourselves - Canada Leads In Raw Cannabis Exports, Not Oil

Canopy Growth Set To Complete Acreage Acquisition, Leaving Some Shareholders Potentially Open To Losses

Canada Cannabis Recent News

Health Canada Cuts $14.6M From Cannabis Program Amid Federal Austerity

Health Canada faces CA$20.5M in cannabis program cuts over 3 years, raising concerns for the legal market amid federal inaction.

NASDAQ-Listed Weed Stock, High Tides Surges Over 21% In Last Two Sessions

Data from Benzinga Pro shows High Tide Inc. shares experienced a significant surge, gaining over 21% in the last two trading sessions.

Cannabis Giant High Tide Taps Into $113 Billion Global E-Commerce Market With New Product Categories

High Tide Inc. (NASDAQ: HITI) (TSXV: HITI) (FSE: 2LYA) is expanding its innovative Cabana Club membership program to the U.S., EU and UK through dedicated websites. "Innovation and market disruption are at the core of High Tide's DNA, and today marks another milestone in our journey," Raj Grover, the company's founder and CEO, said. "I am excited to announce that, in celebration of Cyber Monday, we are taking our highly successful Cabana Club membership program global."High Tide also said it's adding international snacks and confectionery to its e-commerce platform, alongside hemp-derived CBD and cannabis accessories.

PharmaCielo Cannabis Co. Reports 270% YoY Increase In Q3 Revenue, Confident About Profitability In 2025

Cannabis products company PharmaCielo Ltd. (TSXV: PCLO) (OTC: PCLOF) announced on Monday financial and operational results for the three and nine months ended Sept. 30, 2024. The Toronto-based company said revenue for the third quarter totaled CA$1.3 million ($927,772), up from CA$352,000 in the prior year's period. For the nine months, total revenues reached CA$2.4 million, compared to CA$1.3 million in 2023. "PharmaCielo achieved substantial revenue growth, successfully expanded into new international markets, and continued its focus on reducing costs to improve its operational efficiency," Marc Lustig, chairman and CEO of PharmaCielo, said. "Our strategic position in multiple regions, coupled with an expanding product portfolio beyond CBD isolate, has enhanced our ability to serve diverse international markets and generate increased revenue."

Ayurcann Cannabis Co. Reports 28% YoY Net Revenue Growth In Q1 With Strong Performance In Vapes And Pre-Rolls

Ayurcann Holdings Corp. (CSE: AYUR) (OTCQB: AYURF), a Canadian processing and manufacturing company specializing in cannabis 2.0 and 3.0 products, announced on Thursday its first quarter financial and operational results for the three months ended Sept. 30, 2024. The Toronto-based company highlighted a 25% year-over-year increase in gross revenue, strong gross margin and top market presence in the vapes and pre-roll category in Ontario during the period.Ayurcann said fiscal 2024 and the beginning of fiscal 2025 was a pivotal time for Ayurcann and the broader cannabis industry in Canada.

Canadian Cannabis Co. Entourage Health Shares Spike On 8% YoY Q3 Revenue Growth, Reduced Losses

Canadian cannabis producer Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE: 4WE) announced on Friday its third quarter financial results for the three months ended Sept. 30, 2024. The company reported an 8% year-over-year increase to CA$9.5 million ($6.8 million) in net revenue for the period. Sequentially, net revenue increased by 2.1%. George Scorsis, the company's CEO and chair, said the revenue growth is a result of a strategic shift into different markets. The move allowed the company to "diversify and tap into new opportunities," Scorsis said.

Greenway Greenhouse Cannabis Sees 52% YoY Growth In Q2 Revenue Amid Rising Losses And Cost Challenges

Greenway Greenhouse Cannabis Corporation (CSE: GWAY) (OTCQB: GWAYF) reported on Wednesday its second-quarter interim financial statements for the three months ended Sept. 30, 2024. Canadian cultivator of high-quality greenhouse cannabis reported a 52% year-over-year increase in revenue to CA$1.8 million ($1.3 million). Moreover, for the first half of the fiscal year, Greenway's net revenue increased by 78% compared to the same period in 2023.CEO Jamie D'Alimonte highlighted the company's revenue growth, product performance and ongoing commitment to quality cannabis production in a press release issued Wednesday.

Canadian Cannabis Producer C21 Launches Share Buyback, Citing Undervalued Stock Price

Vertically integrated cannabis company C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) announced on Tuesday it will repurchase roughly 5% of its issued and outstanding common shares in order to cancel it.The Canadian cannabis company may buy up to 6,002,390 of its common shares under a normal course issuer bid and cancel them upon their purchase. Vertically integrated cannabis company C21 Investments Inc. (CSE: CXXI) (OTCQX: CXXIF) announced on Tuesday it will repurchase roughly 5% of its issued and outstanding common shares in order to cancel it. What Happened The Canadian cannabis company may buy up to 6,002,390 of its common shares under a normal course issuer bid and cancel them upon their purchase. The buyback program will run for a year, starting Monday, Dec. 2, 2024, using cash on hand for purchases.

Aurora Cannabis Reveals Latest Product Innovations: Ultra-High Potency Indicas And Strains For Veterans

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), announced on Tuesday developments in cannabis science from Aurora's research and genetics facility, Aurora Coast."As a company committed to leading the way in terms of cannabis innovation, we are dedicated to putting patients first by harnessing the innovative solutions developed by our top researchers at Aurora Coast, our unique global research facility," Lana Culley, vice president of science and innovation at Aurora. "We strive to continuously raise the bar on product superiority and overall user experience so that we can deliver on our mission of providing patients with access to the very best medical cannabis."

Canadian Cannabis Producer Cannara Reports 43% YoY Revenue Growth, Boosts Market Share And Profitability

Vertically integrated cannabis producer Cannara Biotech Inc. (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0) announced on Monday its fourth quarter and full fiscal 2024 financial and operating results ended Aug. 31. The Montreal, Canada-based company revealed a 43% year-over-year revenue growth in 2024 to CA$82.2 million ($58.8 million). Gross profit for the full year grew by 32% over the same period, reaching CA$27.9 million, with a gross margin of 34% before fair value adjustments. Positive operating cash flow increased by 81% to CA$10.7 million, while free cash flow turned positive at CA$3.2 million, a CA$7.2 million turnaround from 2023.

EXCLUSIVE: How EQUA Tackles Stigma In Cannabis Insurance With Tailored Solutions

Discover how EQUA tackles stigma in cannabis insurance in Canada with tailored solutions, education, and advocacy to help businesses thrive.

Canadian Cannabis Co. Decibel Reports 12% YoY Drop In Q3 Revenue But Increases Gross Margin To 53%

Decibel Cannabis Company Inc. (TSXV: DB) (OTCQB: DBCCF) announced on Thursday its unaudited interim financial results for the third quarter ending Sept. 30, 2024. "Decibel has been very deliberate about reducing our current liabilities, by ~5mm this quarter," CEO Benjamin Sze said. "Maintaining discipline over time will result in a stronger balance sheet. This marks the last quarter where our primary focus is on Canadian domestic recreational sales. While we continue to integrate AgMedica into our portfolio, it is encouraging to see significant demand internationally for Decibel flower."

What's Happening With Canopy Growth: Is It Time To Buy?

Canopy Growth (NASDAQ: CGC) hovers near $3.93. Fibonacci levels suggest key resistance at $6.36 and support at $3.86. Is it worth the risk?

The U.S. Cannabis Strategy No One's Talking About: Inside Canopy's $300M Plan

Canopy USA offers investors exposure to the U.S. cannabis market without direct regulatory risk through brands like Wana and Jetty.

Medical Marijuana Footprint Grows In Florida As Legalization Push Fizzles, And Other New Cannabis Stores

RISE Dispensaries, a cannabis retail chain owned by Green Thumb Industries Inc. (CSE: GTII) (OTCQX: GTBIF), opened RISE Dispensary Orlando on Good Homes Road on Friday, Nov. 8. Located at 725 Good Homes Road, the new West Orlando location expanded RISE Dispensaries' retail footprint in Florida to 21 locations and 99 nationwide. Cannabis giant Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) opened a new medical dispensary in Miami, Florida in October. Curaleaf Miami Bird Road, located at 8868 SW Bird Rd. in Miami, brought the company's Florida store count to 66 locations, with 151 dispensaries total nationwide.Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), one of the biggest supporters of Amendment 3 which was rejected by Florida voters earlier this month and would have legalized recreational cannabis in the Sunshine State, additionally expanded its already substantial retail footprint statewide.

IM Cannabis: 66% Revenue Growth In Germany, Narrows EBITDA Loss In Q3

International medical cannabis company IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) announced on Thursday its financial results for the third quarter ended Sept. 30, 2024. The company reported revenue from Germany grew 66% year-over-year, reaching CA$5.8 million ($4.1 million). "While the 66% growth we delivered in Germany, to reach $5.8M this quarter is a highlight, we spent the quarter focused on building a solid foundation for 2025," Oren Shuster, the company's CEO, said. "Our goal was to build a strong, consistent supply chain, along with a laser focus on how to improve the efficiency and accuracy of how we use our resources. I believe that the foundation we built this quarter will be the basis we will use to deliver in 2025."

High Tide Closes Final Tranche Of $15M Debt, Plans Retail Growth

High Tide Inc. closes final tranche of $15M debt facility, enhancing financial strength for retail expansion and debt repayment.

Three Paths To Cannabis Profits: Village Farms, Green Thumb, And Jushi Show Divergent Strategies—Which Will Deliver?

Cannabis giants Village Farms, Green Thumb, and Jushi Holdings show distinct strategies for navigating a challenging landscape.

Auxly Cannabis Co.: Q3 Net Revenue Climbs 18% YoY, Adjusted EBITDA Soars

Cannabis-focused consumer packaged goods company Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) released on Friday its financial results for the three and nine months ended Sept. Auxly Cannabis' net revenue totaled CA$33.3 million ($24 million), compared to CA$28.2 million in the prior year's period.

Canopy Growth: Q2 Net Revenue Drops 9% YoY, Projects Positive Earnings Ahead

Canopy Growth reported 9% a year-over-year decrease in net revenue to CA$63 million ($45.4 million). Adjusted EBITDA loss was CA$6 million, representing a 54% improvement year-over-year, driven primarily by the realized benefit of the company's cost savings program. Judy Hong, the company's CFO, said "With expected improvement in top-line growth in the second half of the fiscal year and continued cost discipline, we believe we remain on a path to achieve positive Adjusted EBITDA at the consolidated level in the coming quarters."

Tilray, High Tide, Glass House: How Top Cannabis Companies Deal With Financial Pressures

Discover how cannabis stocks like Tilray, High Tide, and Glass House adapt strategies amid election uncertainty and market volatility.

Beyond Beer, Tilray's $1.67 Billion Market Play: Is This Cannabis Giant Still A Smart Buy?

Zuanic & Associates rates Tilray "Neutral," noting long-term potential but near-term uncertainties, despite cannabis growth in Germany.

Canada's Cannabis Market Goes Cold, Pot Prices Hit Bottom: Why Top Producers Are Losing Ground

Amid this slowdown, certain products capture consumer interest, even as prices stabilize and competition intensifies.